Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in ENTA — Enanta Pharmaceuticals Inc

CIK 1167557 Greenwich, CT
Back to ENTA Full portfolio

Position in ENTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,745,162
-$210,008 QoQ
Shares Held
256,870
-18.0% QoQ
Ownership
0.882%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ENTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. ENTA ranks #94 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in ENTA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,745,162 256,870
2026-03-31 $3,955,170 313,157
2025-12-31 $3,703,345 234,835
2025-09-30 $2,715,332 226,845
2025-06-30 $2,994,590 396,110
2025-03-31 $1,971,239 357,109
2024-12-31 $265,068 46,099
2024-09-30 $392,218 37,859
2024-06-30 $778,264 60,005
2024-03-31 $1,915,465 109,706
2023-12-31 $1,912,713 203,264
2023-09-30 $1,538,957 137,776
2023-06-30 $416,358 19,456
2023-03-31 $403,025 9,966
2022-12-31 $801,400 17,227
2022-09-30 $504,124 9,719
2022-06-30 $354,052 7,490
2022-03-31 $568,941 7,993
2021-12-31 $1,055,370 14,113
2021-09-30 $372,616 6,559
2021-06-30 $350,583 7,966
2021-03-31 $403,141 8,174
2020-12-31 $1,507,053 35,797
2020-09-30 $2,023,338 44,197
2020-06-30 $3,124,367 62,226
2020-03-31 $4,009,225 77,955